Number of the records: 1
Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro'
SYS 0555750 LBL 01000a^^22220027750^450 005 20240103230559.5 014 $a 85109880646 $2 SCOPUS 014 $a 34174419 $2 PUBMED 014 $a 000687935400013 $2 WOS 017 70
$a 10.1016/j.nano.2021.102429 $2 DOI 100 $a 20220318d m y slo 03 ba 101 0-
$a eng 102 $a US 200 1-
$a Nanoaggregate-forming lipid-conjugated AS1411 aptamer as a promising tumor-targeted delivery system of anticancer agents in vitro' 215 $a 13 s. $c E 463 -1
$1 001 cav_un_epca*0344742 $1 011 $a 1549-9634 $e 1549-9642 $1 200 1 $a Nanomedicine: Nanotechnology, Biology and Medicine $v Roč. 36, AUG 2021 (2021) $1 210 $c Elsevier 608 $a Article 610 $a g-quadruplex 610 $a surfactants 610 $a micelle 610 $a sirna 610 $a Nanoaggregates 610 $a Drug delivery 610 $a AS1411 G-quadruplex 610 $a Cervical cancer 610 $a hpv 700 -1
$3 cav_un_auth*0363161 $a Carvalho $b J. $y PT $q Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal, 701 -1
$3 cav_un_auth*0393965 $a Lopes-Nunes $b J. $y PT $q Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal, 701 -1
$3 cav_un_auth*0427426 $a Vialet $b B. $y FR $4 070 $q Univ Bordeaux, CNRS, INSERM, ARNA,UMR 5320,U1212, Bordeaux, France, 701 -1
$3 cav_un_auth*0427427 $a Rosado $b T. $y PT $4 070 $q Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal, Univ Beira Interior, C4 Cloud Comp Competence Ctr, UBIMed, EM506, Covilha, Portugal 701 -1
$3 cav_un_auth*0427428 $a Gallardo $b E. $y PT $4 070 $q Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal, 701 -1
$3 cav_un_auth*0427429 $a Vale $b J. $y PT $4 070 $q Ipatimup Diagnost, Lab Anat Patol, Porto, Portugal, 701 -1
$3 cav_un_auth*0427430 $a Eloy $b C. $y PT $4 070 $q Ipatimup Diagnost, Lab Anat Patol, Porto, Portugal, Univ Porto, Fac Med, Alameda Prof Hernani Monteiro, Porto, Portugal, Univ Porto, Inst Invest & Inovacao Saude I3S, Porto, Portugal 701 -1
$3 cav_un_auth*0427431 $a Ferreira $b S. $y PT $4 070 $q Univ Beira Interior, C4 Cloud Comp Competence Ctr, UBIMed, EM506, Covilha, Portugal, HPRD Hlth Prod Res & Dev Lda, Labfit, Edificio UBIMED, Covilha, Portugal 701 -1
$3 cav_un_auth*0427432 $a Palmeira-de-Oliveira $b R. $y PT $4 070 $q HPRD Hlth Prod Res & Dev Lda, Labfit, Edificio UBIMED, Covilha, Portugal, 701 -1
$3 cav_un_auth*0377581 $a Campello $b M. P. C. $y PT $q Univ Lisbon, Ctr Ciencias & Tecnol Nucl, Inst Super Tecn, Lisbon, Portugal, Univ Lisbon, Inst Super Tecn, DECN Dept Engn & Ciencias Nucl, Lisbon, Portugal 701 -1
$3 cav_un_auth*0377582 $a Paulo $b A. $y PT $q Univ Lisbon, Ctr Ciencias & Tecnol Nucl, Inst Super Tecn, Lisbon, Portugal, Univ Lisbon, Inst Super Tecn, DECN Dept Engn & Ciencias Nucl, Lisbon, Portugal 701 -1
$3 cav_un_auth*0427433 $a Barthelemy $b P. $y FR $4 070 $q Univ Bordeaux, CNRS, INSERM, ARNA,UMR 5320,U1212, Bordeaux, France, 701 -1
$3 cav_un_auth*0347665 $a Mergny $b Jean-Louis $p BFU-R $i Oddělení biofyzikální chemie a molekulární onkologie $j Department of Biophysical Chemistry and Molecular Oncology $l DBCMO $y FR $q CAS, Inst Biophys, Brno, Czech Republic, Ecole Polytech, Inst Polytech Paris, INSERM, CNRS,Lab Opt & Biosci, Palaiseau, France $T Biofyzikální ústav AV ČR, v. v. i. 701 -1
$3 cav_un_auth*0363163 $a Salgado $b G.F. $y FR $q Univ Bordeaux, CNRS, INSERM, ARNA,UMR 5320,U1212, Bordeaux, France, 701 -1
$3 cav_un_auth*0363164 $a Queiroz $b J.A. $y PT $q Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal, 701 -1
$3 cav_un_auth*0427434 $a Ellington $b A. $y US $4 070 $q Univ Texas Austin, Dept Mol Biosci, Austin, TX 78712 USA, 701 -1
$3 cav_un_auth*0048453 $a Cruz $b C. $y PT $z K $q Univ Beira Interior, CICS UBI Ctr Invest Ciencias Saude, Covilha, Portugal, 856 $u https://www.sciencedirect.com/science/article/pii/S1549963421000721?via%3Dihub $9 RIV
Number of the records: 1